Membranous lupus nephritis
- 1 January 2005
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 14 (1), 65-71
- https://doi.org/10.1191/0961203305lu2062oa
Abstract
Membranous lupus nephritis (MLN) represents about 20% of clinically significant renal disease in lupus. Few studies have addressed directly the pathogenesis of MLN. Our assumptions about the underlying mechanisms are based on the combination of extrapolations from idiopathic membranous nephritis (mainly from animal models) and proliferative lupus nephritis. Natural history studies of MLN suggest a relatively low rate of progression to end-stage renal disease but a high rate of significant comorbidities. Historical changes in the criteria for pathologic diagnosis and classification of membranous lupus nephropathy have precluded definitive descriptions of the natural history, prognosis and treatment of this disorder. Patients with membranous lupus nephropathy should be treated early with angiotensin antagonists to minimize proteinuria, as well as lifestyle changes and appropriate drugs to reduce attendant cardiovascular risk factors. In patients with protracted nephrotic syndrome, consideration should be given to immunosuppressive therapies, including corticosteroids, cyclosporine, mycophenolate and cyclophosphamide. Prospective controlled trials are clearly needed in order to establish solid clinical practice guidelines for use of these drugs and other experimental therapies currently under study in membranous lupus nephropathy.This publication has 26 references indexed in Scilit:
- The classification of glomerulonephritis in systemic lupus erythematosus revisitedKidney International, 2004
- New insights into the pathogenesis of membranous nephropathyKidney International, 2000
- Renal Involvement in Systemic Lupus Erythematosus: A Study of 180 Patients from a Single CenterMedicine, 1999
- Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosusArthritis & Rheumatism, 1999
- Treatment of membranous lupus nephritisAmerican Journal of Kidney Diseases, 1998
- Prognostic determinants in lupus nephritis: a long-term clinicopathologic studyLupus, 1995
- Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathyKidney International, 1994
- Elevated urinary excretion of the C5b-9 complex in membranous nephropathyKidney International, 1991
- Therapy of Lupus NephritisThe New England Journal of Medicine, 1986
- MEMBRANOUS LUPUS NEPHROPATHYMedicine, 1977